Ultrasound-Guided Surgery More Effective for Treating Early Form of Breast Cancer
|
By HospiMedica International staff writers Posted on 21 Nov 2022 |

Using ultrasound to guide surgery for patients with ductal carcinoma in situ (DCIS) gives better results than the standard technique of using a wire inserted into the breast, according to new research. The technique, known as intraoperative ultrasound, or IOUS, enables surgeons to remove a smaller quantity of breast tissue, while still removing all the of DCIS tissue. Using IOUS improves the chance of having no cancer cells at the outer edge of the tissue that was removed (known as positive margins), reducing the risk of patients needing a second operation. Because IOUS negates the need for inserting a guide wire, this technique could also reduce pain and preoperative stress for patients and save time for medical staff.
The research carried out by a team at Clinica Universidad de Navarra (Madrid, Spain) involved 108 people who were diagnosed with DCIS and treated between February 2018 and December 2021. Forty-one were treated with IOUS-guided surgery while 67 were treated with surgery guided by wire localization (WL). Following each operation, the tissue removed was analyzed to see how much was removed and whether there were ‘positive margins’. This means that DCIS cells were found at the edge of the tissue removed, suggesting some DCIS cells could have been left behind and patients would probably need a second operation.
Among those treated using WL, seven (10.4%) had positive margins and needed a second operation while in those treated using IOUS, there were only two patients (4.8%) with positive margins who needed a second operation. The patients have been followed up for a year and half so far and cancer has only recurred in one (who was treated with WL). The researchers plan to continue gathering information about patients having surgery for DCIS in the hopes of seeing long-term benefits of using IOUS.
“DCIS is a common form of early breast cancer that can develop into a more serious, invasive cancer. To ensure it does not progress, patients are usually offered surgery. Because DCIS does not usually create lumps in the breast, we need a good technique to guide surgery and make it accurate as possible,” said Dr. Antonio J. Esgueva at Clinica Universidad de Navarra. “As breast surgeons, we want to perform the very best oncological surgery in terms of removing any trace of DCIS but also removing as little of the breast tissue as possible in order to have the best cosmetic result possible. At the same time, we also want to improve patients' experience during treatment by using less invasive techniques and reducing their anxiety. Our research suggests that using intraoperative ultrasound, a quicker and less invasive technique, is effective for guiding DCIS surgery.”
“Once intervention is planned, the standard treatment for patients diagnosed with DCIS is surgery. The need for a second operation due to positive margins can be an issue. This research is promising because it shows that a kinder technique can help guide surgeons to effectively remove DCIS from the breast while minimising unwanted side-effects,” added Dr. Laura Biganzoli, Co-Chair of the European Breast Cancer Conference and Director of the Breast Centre at Santo Stefano Hospital, Prato, Italy, who was not involved in the research.
Related Links:
Clinica Universidad de Navarra
Latest Surgical Techniques News
- Surgical Innovation Cuts Ovarian Cancer Risk by 80%
- New Imaging Combo Offers Hope for High-Risk Heart Patients
- New Classification System Brings Clarity to Brain Tumor Surgery Decisions
- Boengineered Tissue Offers New Hope for Secondary Lymphedema Treatment
- Dual-Energy Catheter Brings New Flexibility to AFib Ablation
- 3D Bioprinting Pushes Boundaries in Quest for Custom Livers
- New AI Approach to Improve Surgical Imaging
- First-Of-Its-Kind Probe Monitors Fetal Health in Utero During Surgery
- Ultrasound Device Offers Non-Invasive Treatment for Kidney Stones
- Light-Activated Tissue Adhesive Patch Achieves Rapid and Watertight Neurosurgical Sealing
- Minimally Invasive Coronary Artery Bypass Method Offers Safer Alternative to Open-Heart Surgery
- Injectable Breast ‘Implant’ Offers Alternative to Traditional Surgeries
- AI Detects Stomach Cancer Risk from Upper Endoscopic Images
- NIR Light Enables Powering and Communicating with Implantable Medical Devices
- Simple Bypass Protocol Improves Outcomes in Chronic Cerebral Occlusion
- Implantable Absorbable Sensor Detects Life-Threatening Complications After Intestinal Surgery
Channels
Artificial Intelligence
view channelCritical Care
view channel
Intranasal Spray to Prevent Illnesses from Respiratory Viruses
Respiratory viruses such as influenza and COVID-19 hospitalize more than one million people in the U.S. each year, with many infections spreading through close contact in households, schools, and workplaces.... Read more
AI Risk Prediction Tool Improves Treatment of Cancer Patients after Heart Attack
Cancer patients who experience a heart attack face a uniquely dangerous combination of risks, including higher chances of death, bleeding, and repeat cardiac events. Because of this complexity, they have... Read moreSurgical Techniques
view channel
Surgical Innovation Cuts Ovarian Cancer Risk by 80%
Ovarian cancer remains the deadliest gynecological cancer, largely because there is no reliable screening test, and most cases are diagnosed at advanced stages. Thousands of patients die each year as treatment... Read more
New Imaging Combo Offers Hope for High-Risk Heart Patients
Patients with type 2 diabetes often develop complex, severe coronary artery disease involving multiple narrowed or blocked arteries, making complete revascularization difficult. Without detailed functional... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Medtronic to Acquire Coronary Artery Medtech Company CathWorks
Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
Mindray North America and Medtronic have expanded their strategic partnership to bring integrated patient monitoring solutions to ambulatory surgery centers across the United States. The collaboration... Read more
FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
Cardiovascular disease remains the world’s leading cause of death, with nearly 18 million fatalities each year, and more than two million patients undergo open-heart surgery annually, most involving sternotomy.... Read more







